REAUTHORIZATION; REPORTING REQUIREMENTS.

SEC. 3003. REAUTHORIZATION; REPORTING REQUIREMENTS. Section 744C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-43) is amended— (1) in subsection (a)(1), by striking “Beginning with fiscal year 2018, not” and inserting “Not”; (2) by striking “Generic Drug User Fee Amendments of 2017” each place it appears and inserting “Generic Drug User Fee Amendments of 2022”; (3) in subsection (a)(2), by striking “Not later than 30 calendar days after the end of the second quarter of fiscal year 2018, and not later than 30 calendar days after the end of each quarter of each fiscal year thereafter” and inserting “Not later than 30 calendar days after the end of each quarter of each fiscal year for which fees are collected under this part”; (4) in subsection (a)(3), by striking “Beginning with fiscal year 2020, the” and inserting “The”; (5) in subsection (b), by striking “Beginning with fiscal year 2018, not” and inserting “Not”; (6) in subsection (c), by striking “Beginning with fiscal year 2018, for” and inserting “For”; and (7) in subsection (f)— (A) in paragraph (1), in the matter preceding subparagraph (A), by striking “fiscal year 2022” and inserting “fiscal year 2027”; and (B) in paragraph (5), by striking “January 15, 2022” and inserting “January 15, 2027”.